Using this approach, we observed that BA was characterized by a loss in cell–cell interaction complexity, dysregulation of FGF23–FGFR1 signaling, and loss of LAMC3–CD44 interactions between hepatic stellate cells and Kupffer cells. The gene discussed is FGF23; the disease is breast angiosarcoma.